Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Coronary Disease
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Stents

abstract

  • For coronary revascularization, abciximab and stent implantation confer complementary long-term clinical benefits.

publication date

  • July 29, 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM199907293410503

PubMed ID

  • 10423466

Additional Document Info

start page

  • 319

end page

  • 27

volume

  • 341

number

  • 5